U.S. Food and Drug Administration Approves Venetoclax (VENCLEXTA) For Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia – With or Without 17p Deletion
New York, NY (June 8, 2018) – The U.S. Food and Drug Administration (FDA) announced…
New York, NY (June 8, 2018) – The U.S. Food and Drug Administration (FDA) announced…
New York, NY (May 1, 2018) –The U.S. Food and Drug Administration (FDA) announced it…
New York, NY (March 20, 2018) –The U.S. Food and Drug Administration (FDA) announced it…
New York, NY (October 19, 2017) – The U.S. Food and Drug Administration (FDA) announced…
New York, NY (October 31, 2017) –The U.S. Food and Drug Administration (FDA) announced it…
New York, NY (November 9, 2017) –The U.S. Food and Drug Administration (FDA) announced it…
New York, NY (October 31, 2017) –The U.S. Food and Drug Administration (FDA) announced it…
New York, NY (September 14, 2017) – The U.S. Food and Drug Administration (FDA) announced…
New York, NY (August 3, 2017) – New York, NY – The U.S. Food and…
New York, NY (June 5, 2017) – The U.S. Food and Drug Administration (FDA) announced…